● Recruiting

A Multicenter Prospective Study on the Performance of Spectral CT for Evaluating Treatment Response After TACE in Hepatocellular Carcinoma

Condition: HCC - Hepatocellular Carcinoma · TACE(Transcatheter Arterial Chemoembolization) · Sponsor: Zhongda Hospital

PhaseN/A

Planned participants121

Who can joinAll sexes, 18 Years to 75 Years

Healthy volunteersNo

About this study

By comparing the diagnostic accuracy of spectral CT and conventional CT in evaluating treatment response efficacy after TACE, this study aims to investigate the diagnostic performance of spectral CT in assessing treatment response following TACE for hepatocellular carcinoma.

This description comes directly from the study's public registry record.

Talk to the study team

Shuhang Zhang · 86 13852914095 · shuhangzhang@outlook.com

Always discuss trial participation with your own doctor first.

Locations (1)

Zhongda Hospital Southeast University

Nanjing, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07351669